The global pharmaceutical water market size is calculated at USD 47.47 billion in 2025 and is forecasted to reach around USD 99.30 billion by 2034, accelerating at a CAGR of 8.55% from 2025 to 2034. The North America pharmaceutical water market size surpassed USD 14.97 billion in 2024 and is expanding at a CAGR of 8.70% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Pharmaceutical Water Industry Impact
5.2. Pharmaceutical Water Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Water Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Water Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Water Market Revenue by Market Players
7.1.1.2. Pharmaceutical Water Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
8.1. Pharmaceutical Water Market, by Product Type
8.1.1. HPLC Grade Water
8.1.1.1. Market Revenue and Forecast
8.1.2. Water for Injection
8.1.2.1. Market Revenue and Forecast
9.1. Pharmaceutical Water Market, by Application
9.1.1. Pharmaceutical & Biotechnology Companies
9.1.1.1. Market Revenue and Forecast
9.1.2. Academics & Research Laboratories
9.1.2.1. Market Revenue and Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product Type
10.1.2. Market Revenue Forecast by Application
10.1.3. U.S
10.1.3.1. Market Revenue Forecast
10.1.4. Canada
10.1.4.1. Market Revenue Forecast
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type
10.2.2. Market Revenue Forecast by Application
10.2.3. UK
10.2.3.1. Market Revenue Forecast
10.2.4. Germany
10.2.4.1. Market Revenue Forecast
10.2.5. France
10.2.5.1. Market Revenue Forecast
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type
10.3.2. Market Revenue Forecast by Application
10.3.3. China
10.3.3.1. Market Revenue Forecast
10.3.4. India
10.3.4.1. Market Revenue Forecast
10.3.5. Japan
10.3.5.1. Market Revenue Forecast
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type
10.4.2. Market Revenue Forecast by Application
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type
10.5.2. Market Revenue Forecast by Application
10.5.3. GCC
10.5.3.1. Market Revenue Forecast
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast
11.1. Baxter International, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Merck KGaA
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. B. Braun Melsungen AG
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Thermo Fisher Scientific, Inc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. Cytiva (Danaher)
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Fresenius Kabi AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Pfizer, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. CovaChem, LLC
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Intermountain Life Sciences
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Standard Reagents, Pvt. Ltd
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample